WO1998046348A1 - Heat resistant lipid vesicles - Google Patents

Heat resistant lipid vesicles Download PDF

Info

Publication number
WO1998046348A1
WO1998046348A1 PCT/US1998/007451 US9807451W WO9846348A1 WO 1998046348 A1 WO1998046348 A1 WO 1998046348A1 US 9807451 W US9807451 W US 9807451W WO 9846348 A1 WO9846348 A1 WO 9846348A1
Authority
WO
WIPO (PCT)
Prior art keywords
lipid
oil
lipid vesicle
group
polyoxyethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1998/007451
Other languages
French (fr)
Inventor
Rajiv Mathur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IGEN Inc
Original Assignee
IGEN Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IGEN Inc filed Critical IGEN Inc
Priority to DE69831144T priority Critical patent/DE69831144D1/en
Priority to EP98915548A priority patent/EP0973605B1/en
Priority to CA002286096A priority patent/CA2286096C/en
Priority to JP54419198A priority patent/JP2001523230A/en
Publication of WO1998046348A1 publication Critical patent/WO1998046348A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06Lipsticks
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]
    • Y10T428/2985Solid-walled microcapsule from synthetic polymer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989Microcapsule with solid core [includes liposome]

Definitions

  • the present invention relates to lipid vesicles which remain stable at high temperatures. This heat resistance is due in part to the presence of at least one high melting point compound in their lipid bilayers.
  • blended lipid vesicles made up of at least two surfactants surrounding an aqueous or oil-filled central cavity provide several advantages when used in forming cosmetic preparations.
  • One advantage provided by blended lipid vesicles is the ability to incorporate water and water-soluble compounds into the lipid vesicles which can then be mixed with oily bases to improve their consistency.
  • these lipid vesicles can break down as the structural components making up their lipid bilayers melt.
  • lipid vesicles which are stable at high temperatures (e.g., above 80°C) and which do not break down when used in cosmetic or dermatologic compounds which are heated to high temperatures (e.g., 80°C or higher) during manufacture.
  • One cosmetic, in particular, which undergoes high temperature processing during manufacture is lipstick.
  • Conventional lipstick manufacture requires heating color pigments and a fatty base, which typically includes waxes, oils and other fats, and uniformly blending the mixture.
  • the base and pigments are generally heated to at least about 85°C in a steam jacketed kettle. Once molten, they are blended and then molded, allowing for the release of any trapped air. After cooling, the appearance of the lipstick is often refined by passing it through a gas flame to rapidly reheat its surface, leaving a glossy finish.
  • lipid vesicles of the prior art Due to the high temperature processing used during the manufacture of lipstick and other similar cosmetics, blended lipid vesicles of the prior art have not been practical for use in these compounds. Accordingly, it is another object of the present invention to provide lipid vesicles which can be used in a lipstick preparation.
  • the present invention features heat resistant lipid vesicles which can be used in the manufacture of products which are processed at high temperatures, for example, of greater than 80°C.
  • the lipid vesicles are rendered heat stable by incorporating into their lipid bilayers at least one ethoxylated alcohol having a long, substantially linear C20-C50 carbon chain.
  • the long fatty carbon chain relative to the polar ethoxylated head 'group of this molecule gives it a high melting point compared to conventional surfactants used to prepare lipid vesicles which typically have carbon chains in the range of Ci4-C 2 2-
  • the lipid vesicles of the present invention are therefore particularly useful in the manufacture of oil and/or wax based cosmetics or dermatologies which must be heated to temperatures of about 80°C or higher to melt the fatty cosmetic base and to achieve sufficient blending with other components such as dyes, oils and fragrances.
  • the present invention provides lipid vesicles which have as the major structural components of their lipid bilayers a blend of non- ionic surfactants including a primary surfactant and at least one ethoxylated alcohol having a substantially linear C20-C50 carbon chain.
  • the lipid bilayers further include a sterol which acts as a membrane modulator to increase the shape and form of the lipid vesicles as well as their stability.
  • the primary lipid which constitutes the greatest structural lipid by weight of the bilayers (e.g., 10-20%), can be any suitable non-ionic surfactant known in the art to be useful in forming lipid vesicles.
  • suitable surfactants are disclosed in US 5,260,065, entitled “Blended Lipid Vesicles;” US 5,234,767, entitled “Lipid Hybrid Vesicles;” US 5,439,967 entitled “Propylene Glycol Stearate Vesicles;” US 5,405,615, entitled “Sucrose Distearate Vesicles;” US 5,160,669, entitled “Method of Making Oil Filled Paucilamellar Lipid Vesicles, the contents all of which are incorporated by reference herein.
  • the primary lipid of the vesicle bilayers is selected from the group consisting of polyoxyethylene glyceryl fatty acid esters (e.g., having 1- 10 polyoxyethylene groups), such as polyoxyethylene glyceryl monostearate and polyoxyethylene glyceryl monooleate, glycol monoesters, C ⁇ -C j g glyceryl mono-and diesters, and mixtures thereof.
  • Preferred primary lipids are selected from the group consisting of C j g and g fatty alcohols, glyceryl mono- and distearate, glyceryl dilaurate, glycol stearate, and mixtures thereof. All of the aforementioned compounds are commercially available.
  • Sterols useful in forming the lipid bilayers also include any sterol known in the art to be useful as modulators of lipid membranes. Suitable sterols include but are not limited to cholesterol, cholesterol derivatives, hydrocortisone, phytosterol, or mixtures thereof. In one embodiment, the sterol is phytosterol supplied from avocado oil unsaponifiables. The use of this sterol, in particular, to form lipid vesicles is described in U.S. Serial No. 08/345,223, entitled Lipid Vesicles Containing avocado Oil Unsaponifiables, the contents of which are incorporated by reference herein.
  • the primary lipid and sterol are mixed with at least one ethoxylated alcohol derived from a primary alcohol having a C20-C 5 0 average carbon chain, preferably derived from a primary alcohol.
  • the ethoxylated alcohol comprises about 20- 80% by weight ethylene oxide (e.g., 2.6-4.0 ethylene oxides per mole) and has a hydroxyl number ranging from about 20-85.
  • the long, substantially linear carbon chain of the ethoxylated alcohol gives it a high melting point and makes the lipid vesicles resistant to breakdown at high temperatures.
  • Preferred ethoxylated alcohols have a melting point of at least about 80°C, more preferably at least about 90°C, and more preferably at least about 100°C or higher.
  • Such compounds can be purchased from Petrolite Corporation (Tulsa, OK) under the brand name UNITHOXTM ethoxylated alcohols.
  • Preferred UNITHOXTM ethoxylated alcohols for use in the present invention include UNITHOXTM 420 having a melting point of 91 °C, UNITHOXTM 520 having a melting point of 99°C and most preferably UNITHOXTM 720 having a melting point of 106°C.
  • high melting point compounds may also be used in place of, or in addition to, the ethoxylated alcohol.
  • high melting point lipids such as ceramides (e.g., phytoceramides) and other sphingolipids (e.g., N-oleoyl-phytosphingosine), can be used in the lipid bilayers of the vesicles to provide high temperature stability and additional moisture when the vesicles are used in dermatological or cosmetic formulations.
  • lipid vesicles of the present invention When used in preparations which are processed at high temperatures, such as cosmetic and/or dermatologic preparations, lipid vesicles of the present invention should be made with ethoxylated alcohols which have a melting point which is greater than the highest temperature reached during processing of the preparation. Therefore, the lipid vesicles can be tailored for use in particular products according to the conditions of manufacture of the product. In general, the ethoxylated alcohol or other high melting point compound (e.g., phytoceramides), or combination thereof, is present as approximately 10-25% of the total lipid (by weight) of the vesicles.
  • the ethoxylated alcohol or other high melting point compound e.g., phytoceramides
  • the lipid bilayers of the vesicles can further contain one or more secondary surfactants in addition to the primary surfactant(s), the sterol and the ethoxylated alcohol.
  • Suitable secondary surfactants include but are not limited to polyoxyethylene acyl alcohols, Ci ⁇ -Qg fatty alcohols, quaternary dimethyldiacyl amines, polyoxyethylene sorbitan alcohols, polyglycerols, sorbitan fatty acids esters, fatty acids and their salts, and mixtures thereof.
  • stearyl alcohol and a polyoxyethylene 10-20 stearyl alcohol are used together as secondary surfactants.
  • the lipid vesicles of the present invention can further contain an oil to improve the shape and consistency of the vesicles, as well as to lower the solidification temperature of the products in which the vesicles are used.
  • oils known in the art can be used for this purpose including, but not limited to, castor oil, soybean oil, squalene oil, squalane oil, sesame oil, olive oil, canola oil, corn oil, rapeseed oil, safflower oil, sunflower oil, fish oils, avocado oil, water insoluble vitamins, and mixtures thereof.
  • the oil can also contain a dye to color the vesicles for use in cosmetics.
  • the oil partitions to the central core of the vesicles while the remaining lipid surfactants are incorporated into the lipid bilayers which surround the core.
  • the lipid vesicles are paucilamellar vesicles having 2-10 bilayers surrounding an amorphous central cavity.
  • the above-described lipid components are blended at a sufficiently high temperature to form an even, homogenous lipid phase. In general, this temperature ranges from about 75-95°C, preferably about 80-90°C.
  • a separate aqueous phase is formed which can contain water-soluble components, such as emulsifiers and preservatives, to further improve the form, consistency and stability of the vesicle preparation.
  • Polyoxyethylene 20 sorbitan ester (Tween 80) is added to the aqueous phase in an amount which ranges from 1.5-3.0% by weight.
  • the lipid phase is then shear mixed with the aqueous phase under conditions sufficient to allow formation of the vesicles.
  • This can be achieved using many different techniques known in the art.
  • the lipid phase and the aqueous phase are shear mixed as described in US 5,163,809, entitled “ Method and Apparatus for Producing Lipid Vesicles", the disclosure of which is incorporated herein by reference.
  • the term "shear mixing,” as used herein, means a shear equivalent to a relative flow of 5-50 m/s through a 1mm orifice.
  • the lipid vesicles of the present invention can be used in a wide variety of products, such as cosmetics and dermatologies, to improve the consistency, uniformity and moisture levels of the product.
  • the lipid vesicles are used in a lipstick preparation which is formed by blending the vesicles with a fatty lipstick base at a high temperature of 80°C or greater.
  • a lipstick preparation which is formed by blending the vesicles with a fatty lipstick base at a high temperature of 80°C or greater.
  • Conventional materials and techniques known in the art for forming lipsticks may be employed using the lipid vesicles of the present invention.
  • the vesicles are heated to at least about 80-85°C with a lipstick base made up of color pigments, waxes, oils and other fats conventionally used in lipstick bases.
  • the lipstick base also can contain emulsifiers to help suspend and disperse the lipid vesicles.
  • polyethylene glycol hydrogenated castor oil (which can be purchased under the brand name CREMAPHORTM) is added in the base (i.e., exterior to the lipid vesicles) in an amount which is approximately 10% by weight of the base.
  • a steam jacketed kettle or other suitable apparatus can be used to heat the vesicles and lipstick base.
  • the mixture is then uniformly blended (allowing for the release of any trapped air), poured into a mold and allowed to cool. Further processing, such as flash flaming, can be employed to improve the gloss and shape of the final lipstick product.
  • lipid vesicles were made using the procedure described below using ethoxylated alcohols selected from UNITHOX TM 420, 520 or 720. These ethoxylated alcohols contain 2.6-4.0 ethylene oxides per mole and have average molecular weights of 560, 700 and 875, respectively.
  • Vesicles (corresponding to Samples A-C) were also made with varying percentages of Tween 80 (1.5%, 2.0%. 2.5% and 3.0%) and with 10% mineral oil instead of 20% castor oil to determine the effect on the lipid vesicles. Lipid vesicles were formed in all samples, however, the samples listed above as A-C represent the best results in terms of lipid size, shape and homogeneity.
  • Lipid vesicles were formed using the hot loading technique described in United States Patent No. 4,911,928, the disclosure of which is incorporated herein by reference.
  • the lipid phase listed in Table 1 was hydrated with 35.0 ml of deionized water at 70°C. Hydration was achieved by shear mixing the lipid and aqueous phases using two heated 60 cc syringes.
  • a flow device such as the NovaMixTM vesicle former is used.
  • the basic details of the NovaMixTM system are described in United States Patent No. 4,895,452, the disclosure of which is incorporated herein by reference.
  • Sample C containing UNITHOX TM 720 produced the nicest looking, most homogenous population of vesicles of the three samples (i.e., A-C). However, all three samples produced visible lipid vesicles.
  • Lipid vesicles were formed by heating the lipid phase (15.05 g or 17.3 ml) to 95°C and then hydrating the lipid phase with 35.05 ml of deionized water at 65°C. Hydration was achieved by shear mixing the lipid and aqueous phases using two 60 cc syringes.
  • heat resistant lipid vesicles were formed at high temperature using a lower total percentage of surfactants and a higher total percentage of ethoxylated alcohol compared to the vesicles prepared in Examples 1 and 2.
  • Polyoxyethylene 9 glyceryl monostearate POE 9 GMS
  • POE 9 GMS Polyoxyethylene 9 glyceryl monostearate
  • glyceryl distearate e.g., glyceryl distearate, stearyl alcohol, polyoxyethylene 10 stearyl alcohol and polyoxyethylene 20 sorbitan ester
  • phytosterol was used in place of cholesterol.
  • Lipid vesicles were formed by heating the lipid phase to 100°C and then hydrating the lipid phase with 35.05 ml of deionized water at 95°C. Hydration was achieved by shear mixing the lipid and aqueous phases using two 60 cc syringes.
  • Samples A and B exhibited a thick, creamy consistency. Sample C was similar to Sample A but not as viscous. Sample D was fluid compared to samples A-C. One day later, the samples exhibited the same consistency.
  • Samples A-C all contained a substantially uniform population of small, nicely shaped (e.g., spherical) vesicles, with Sample A being the best of the three samples.
  • Sample D had fewer vesicles which were larger than those of Samples A-C.
  • Microscopic examination showed smaller sized vesicles in Sample C compared to Samples A and B.
  • Example 2 the lipid vesicles from Example 1 were used in lipstick preparations.
  • Each sample A-C was mixed using a vortex mixer in a test tube with melted lipstick base made up of the components shown below in Table 4 at a ratio of 1.0 g (vesicles) to 4.0 g (base).
  • the samples were then placed in a water bath at 80°C. Aliquots were taken after 0, 1 , 2, 3, and 4 hours and placed on a slide, diluted with castor oil and observed under a microscope.
  • lipid vesicles of the present invention made with at least one high melting point ethoxylated alcohol such as UNITHOX TM 420, 520 or 720 remain stable when processed with other cosmetic components at high temperatures of at least 80°C for an extended period of time.
  • high melting point ethoxylated alcohol such as UNITHOX TM 420, 520 or 720
  • the lipstick preparation described in Example 4 was modified by adding various Polyethylene glycol (PEG) hydrogenated castor oil preparations (sold under the brand name CREMAPHORTM) to help disperse and maintain suspension of the lipid vesicles in the lipstick base.
  • PEG Polyethylene glycol
  • the PEG hydrogenated castor oil was added at both 10% total base mix (e.g., 2.5 g, as shown in Table 3) and at 5% total base mix (e.g., 1.25 g).
  • the lipid vesicles and lipstick preparation was prepared as described in Example 3 using 1.0 g of vesicles and 9.0 g of base mix with PEG hydrogenated castor oil.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Lipid vesicles which remain stable at high temperatures are disclosed. The vesicles contain as a component of their lipid bilayers at least one ethoxylated alcohol having a linear C20-C50 carbon chain. Also disclosed is a method of making the vesicles. The lipid vesicles are useful in forming cosmetic and dermatologic preparations, such as lipstick, which are processed at high temperatures (e.g., at 80 °C or above) during manufacture.

Description

HEAT RESISTANT LIPID VESICLES
Background of the Invention
The present invention relates to lipid vesicles which remain stable at high temperatures. This heat resistance is due in part to the presence of at least one high melting point compound in their lipid bilayers.
As described in US 5,260,065, the contents of which are incorporated by reference herein, blended lipid vesicles made up of at least two surfactants surrounding an aqueous or oil-filled central cavity provide several advantages when used in forming cosmetic preparations. One advantage provided by blended lipid vesicles is the ability to incorporate water and water-soluble compounds into the lipid vesicles which can then be mixed with oily bases to improve their consistency. However, when used in cosmetic or dermatologic compounds which are heated to high temperatures (e.g., 80°C or higher) during manufacture, these lipid vesicles can break down as the structural components making up their lipid bilayers melt. Accordingly, it is an object of the present invention to provide lipid vesicles which are stable at high temperatures (e.g., above 80°C) and which do not break down when used in cosmetic or dermatologic compounds which are heated to high temperatures (e.g., 80°C or higher) during manufacture.
One cosmetic, in particular, which undergoes high temperature processing during manufacture is lipstick. Conventional lipstick manufacture requires heating color pigments and a fatty base, which typically includes waxes, oils and other fats, and uniformly blending the mixture. The base and pigments are generally heated to at least about 85°C in a steam jacketed kettle. Once molten, they are blended and then molded, allowing for the release of any trapped air. After cooling, the appearance of the lipstick is often refined by passing it through a gas flame to rapidly reheat its surface, leaving a glossy finish.
Due to the high temperature processing used during the manufacture of lipstick and other similar cosmetics, blended lipid vesicles of the prior art have not been practical for use in these compounds. Accordingly, it is another object of the present invention to provide lipid vesicles which can be used in a lipstick preparation.
Summary of the Invention
The present invention features heat resistant lipid vesicles which can be used in the manufacture of products which are processed at high temperatures, for example, of greater than 80°C. The lipid vesicles are rendered heat stable by incorporating into their lipid bilayers at least one ethoxylated alcohol having a long, substantially linear C20-C50 carbon chain. The long fatty carbon chain relative to the polar ethoxylated head 'group of this molecule gives it a high melting point compared to conventional surfactants used to prepare lipid vesicles which typically have carbon chains in the range of Ci4-C22- The lipid vesicles of the present invention are therefore particularly useful in the manufacture of oil and/or wax based cosmetics or dermatologies which must be heated to temperatures of about 80°C or higher to melt the fatty cosmetic base and to achieve sufficient blending with other components such as dyes, oils and fragrances.
Accordingly, in one embodiment, the present invention provides lipid vesicles which have as the major structural components of their lipid bilayers a blend of non- ionic surfactants including a primary surfactant and at least one ethoxylated alcohol having a substantially linear C20-C50 carbon chain. The lipid bilayers further include a sterol which acts as a membrane modulator to increase the shape and form of the lipid vesicles as well as their stability.
The primary lipid, which constitutes the greatest structural lipid by weight of the bilayers (e.g., 10-20%), can be any suitable non-ionic surfactant known in the art to be useful in forming lipid vesicles. For example, suitable surfactants are disclosed in US 5,260,065, entitled "Blended Lipid Vesicles;" US 5,234,767, entitled "Lipid Hybrid Vesicles;" US 5,439,967 entitled "Propylene Glycol Stearate Vesicles;" US 5,405,615, entitled "Sucrose Distearate Vesicles;" US 5,160,669, entitled "Method of Making Oil Filled Paucilamellar Lipid Vesicles, the contents all of which are incorporated by reference herein. In one embodiment, the primary lipid of the vesicle bilayers is selected from the group consisting of polyoxyethylene glyceryl fatty acid esters (e.g., having 1- 10 polyoxyethylene groups), such as polyoxyethylene glyceryl monostearate and polyoxyethylene glyceryl monooleate,
Figure imgf000004_0001
glycol monoesters, C^-Cjg glyceryl mono-and diesters, and mixtures thereof. Preferred primary lipids are selected from the group consisting of Cjg and g fatty alcohols, glyceryl mono- and distearate, glyceryl dilaurate, glycol stearate, and mixtures thereof. All of the aforementioned compounds are commercially available.
Sterols useful in forming the lipid bilayers also include any sterol known in the art to be useful as modulators of lipid membranes. Suitable sterols include but are not limited to cholesterol, cholesterol derivatives, hydrocortisone, phytosterol, or mixtures thereof. In one embodiment, the sterol is phytosterol supplied from avocado oil unsaponifiables. The use of this sterol, in particular, to form lipid vesicles is described in U.S. Serial No. 08/345,223, entitled Lipid Vesicles Containing Avocado Oil Unsaponifiables, the contents of which are incorporated by reference herein. The primary lipid and sterol are mixed with at least one ethoxylated alcohol derived from a primary alcohol having a C20-C50 average carbon chain, preferably derived from a primary alcohol. In general, the ethoxylated alcohol comprises about 20- 80% by weight ethylene oxide (e.g., 2.6-4.0 ethylene oxides per mole) and has a hydroxyl number ranging from about 20-85. The long, substantially linear carbon chain of the ethoxylated alcohol gives it a high melting point and makes the lipid vesicles resistant to breakdown at high temperatures. Preferred ethoxylated alcohols have a melting point of at least about 80°C, more preferably at least about 90°C, and more preferably at least about 100°C or higher. Such compounds can be purchased from Petrolite Corporation (Tulsa, OK) under the brand name UNITHOX™ ethoxylated alcohols. Preferred UNITHOX™ ethoxylated alcohols for use in the present invention include UNITHOX™ 420 having a melting point of 91 °C, UNITHOX™ 520 having a melting point of 99°C and most preferably UNITHOX™ 720 having a melting point of 106°C.
Other high melting point compounds (e.g., having a melting point of at least about 80°C) may also be used in place of, or in addition to, the ethoxylated alcohol. For example, high melting point lipids, such as ceramides (e.g., phytoceramides) and other sphingolipids (e.g., N-oleoyl-phytosphingosine), can be used in the lipid bilayers of the vesicles to provide high temperature stability and additional moisture when the vesicles are used in dermatological or cosmetic formulations.
When used in preparations which are processed at high temperatures, such as cosmetic and/or dermatologic preparations, lipid vesicles of the present invention should be made with ethoxylated alcohols which have a melting point which is greater than the highest temperature reached during processing of the preparation. Therefore, the lipid vesicles can be tailored for use in particular products according to the conditions of manufacture of the product. In general, the ethoxylated alcohol or other high melting point compound (e.g., phytoceramides), or combination thereof, is present as approximately 10-25% of the total lipid (by weight) of the vesicles.
The lipid bilayers of the vesicles can further contain one or more secondary surfactants in addition to the primary surfactant(s), the sterol and the ethoxylated alcohol. Suitable secondary surfactants include but are not limited to polyoxyethylene acyl alcohols, Ci β-Qg fatty alcohols, quaternary dimethyldiacyl amines, polyoxyethylene sorbitan alcohols, polyglycerols, sorbitan fatty acids esters, fatty acids and their salts, and mixtures thereof. In one embodiment, stearyl alcohol and a polyoxyethylene 10-20 stearyl alcohol are used together as secondary surfactants. Some of the aforementioned compounds are commercially available and be purchased, for example, from ICI Americas, Inc. (Wilmington, De.) under the trade names BRIJ™ (polyoxyethylene fatty ethers), SPAN™ (sorbitan fatty acid esters), and TWEEN™ (ethoxylated sorbitan fatty acid esters). In addition to the primary alcohol, sterol and ethoxylated alcohol having a linear C20-C50 carbon chain derived from a primary alcohol, the lipid vesicles of the present invention can further contain an oil to improve the shape and consistency of the vesicles, as well as to lower the solidification temperature of the products in which the vesicles are used. A wide variety of oils known in the art can be used for this purpose including, but not limited to, castor oil, soybean oil, squalene oil, squalane oil, sesame oil, olive oil, canola oil, corn oil, rapeseed oil, safflower oil, sunflower oil, fish oils, avocado oil, water insoluble vitamins, and mixtures thereof. The oil can also contain a dye to color the vesicles for use in cosmetics. During manufacture of the vesicles, the oil partitions to the central core of the vesicles while the remaining lipid surfactants are incorporated into the lipid bilayers which surround the core. In one embodiment, the lipid vesicles are paucilamellar vesicles having 2-10 bilayers surrounding an amorphous central cavity. To form the lipid vesicles of the present invention, the above-described lipid components are blended at a sufficiently high temperature to form an even, homogenous lipid phase. In general, this temperature ranges from about 75-95°C, preferably about 80-90°C. In addition, a separate aqueous phase is formed which can contain water-soluble components, such as emulsifiers and preservatives, to further improve the form, consistency and stability of the vesicle preparation. In one embodiment, Polyoxyethylene 20 sorbitan ester (Tween 80) is added to the aqueous phase in an amount which ranges from 1.5-3.0% by weight.
The lipid phase is then shear mixed with the aqueous phase under conditions sufficient to allow formation of the vesicles. This can be achieved using many different techniques known in the art. In a preferred embodiment, the lipid phase and the aqueous phase are shear mixed as described in US 5,163,809, entitled " Method and Apparatus for Producing Lipid Vesicles", the disclosure of which is incorporated herein by reference. The term "shear mixing," as used herein, means a shear equivalent to a relative flow of 5-50 m/s through a 1mm orifice. The lipid vesicles of the present invention can be used in a wide variety of products, such as cosmetics and dermatologies, to improve the consistency, uniformity and moisture levels of the product. In one embodiment of the invention, the lipid vesicles are used in a lipstick preparation which is formed by blending the vesicles with a fatty lipstick base at a high temperature of 80°C or greater. Conventional materials and techniques known in the art for forming lipsticks may be employed using the lipid vesicles of the present invention. In one method, the vesicles are heated to at least about 80-85°C with a lipstick base made up of color pigments, waxes, oils and other fats conventionally used in lipstick bases. The lipstick base also can contain emulsifiers to help suspend and disperse the lipid vesicles. In one embodiment, polyethylene glycol hydrogenated castor oil (which can be purchased under the brand name CREMAPHOR™) is added in the base (i.e., exterior to the lipid vesicles) in an amount which is approximately 10% by weight of the base.
To heat the vesicles and lipstick base, a steam jacketed kettle or other suitable apparatus can be used. The mixture is then uniformly blended (allowing for the release of any trapped air), poured into a mold and allowed to cool. Further processing, such as flash flaming, can be employed to improve the gloss and shape of the final lipstick product.
Other uses and modifications of the products and methods of the invention will be apparent from the following description and the claims.
Detailed Description of the Invention The following formulations will illustrate certain embodiments of the invention.
These examples are merely illustrative and those skilled in the art may be able to determine other materials and methods which accomplish the same results. Such other materials and methods are included within the scope of the invention.
EXAMPLE 1
In this Example, heat resistant lipid vesicles were made using the procedure described below using ethoxylated alcohols selected from UNITHOX ™ 420, 520 or 720. These ethoxylated alcohols contain 2.6-4.0 ethylene oxides per mole and have average molecular weights of 560, 700 and 875, respectively. Vesicles (corresponding to Samples A-C) were also made with varying percentages of Tween 80 (1.5%, 2.0%. 2.5% and 3.0%) and with 10% mineral oil instead of 20% castor oil to determine the effect on the lipid vesicles. Lipid vesicles were formed in all samples, however, the samples listed above as A-C represent the best results in terms of lipid size, shape and homogeneity. TABLE 1
Figure imgf000008_0001
Lipid vesicles were formed using the hot loading technique described in United States Patent No. 4,911,928, the disclosure of which is incorporated herein by reference. In this procedure, the lipid phase listed in Table 1 was hydrated with 35.0 ml of deionized water at 70°C. Hydration was achieved by shear mixing the lipid and aqueous phases using two heated 60 cc syringes. However, in this and the following Examples, any method of achieving the proper shear could be used. For example, a flow device such as the NovaMix™ vesicle former is used. The basic details of the NovaMix™ system are described in United States Patent No. 4,895,452, the disclosure of which is incorporated herein by reference.
After processing to form lipid vesicles, the samples were observed under a microscope using polarized light. Sample C containing UNITHOX ™ 720 produced the nicest looking, most homogenous population of vesicles of the three samples (i.e., A-C). However, all three samples produced visible lipid vesicles.
EXAMPLE 2
In this Example, heat resistant lipid vesicles were formed at high temperature using the components of Sample C from Example 1 (containing UNITHOX ™ 720) (Sample A) with preservatives methyl paraben and propyl paraben (Sample B), and with substitution of 20% of the water with glycerine (Sample C). TABLE 2
Figure imgf000009_0001
Lipid vesicles were formed by heating the lipid phase (15.05 g or 17.3 ml) to 95°C and then hydrating the lipid phase with 35.05 ml of deionized water at 65°C. Hydration was achieved by shear mixing the lipid and aqueous phases using two 60 cc syringes.
After processing to form lipid vesicles, the samples were observed under a microscope using polarized light. A heterogeneous population of vesicles, including many small and medium sized, spherical structures had formed in each sample. Microscopic examination showed smaller sized vesicles in Sample C compared to Samples A and B.
EXAMPLE 3
In this Example, heat resistant lipid vesicles were formed at high temperature using a lower total percentage of surfactants and a higher total percentage of ethoxylated alcohol compared to the vesicles prepared in Examples 1 and 2. Polyoxyethylene 9 glyceryl monostearate (POE 9 GMS) was used in place of the surfactants used in Examples 1 and 2 (e.g., glyceryl distearate, stearyl alcohol, polyoxyethylene 10 stearyl alcohol and polyoxyethylene 20 sorbitan ester). In addition, phytosterol (Generol™ 122N) was used in place of cholesterol. TABLE 3
Figure imgf000010_0001
Lipid vesicles were formed by heating the lipid phase to 100°C and then hydrating the lipid phase with 35.05 ml of deionized water at 95°C. Hydration was achieved by shear mixing the lipid and aqueous phases using two 60 cc syringes.
After processing to form lipid vesicles and cooling, the samples were checked for consistency and observed under a microscope using polarized light.
Samples A and B exhibited a thick, creamy consistency. Sample C was similar to Sample A but not as viscous. Sample D was fluid compared to samples A-C. One day later, the samples exhibited the same consistency.
Under microscopic examination, Samples A-C all contained a substantially uniform population of small, nicely shaped (e.g., spherical) vesicles, with Sample A being the best of the three samples. Sample D had fewer vesicles which were larger than those of Samples A-C. Microscopic examination showed smaller sized vesicles in Sample C compared to Samples A and B.
To test the heat resistance of the vesicles, Samples A-D were placed in a water bath at 85°C. Aliquots from the samples were checked under a microscope at 1.5, 2.5 and 3.5 hours.
At 1.5 and 2.5 hours, the samples all appeared the same as they started (i.e., at 0 hours). At 3.5 hours vesicles were still present in all four samples. However, in Samples B-D, other non-vesicle lipid structures (odd-shaped structures) also were visible. Sample A retained the same appearance as it did at the start (i.e., 0 hours). Therefore, it was concluded that Sample A was the best of the four samples in consistency, vesicle size/shape, and heat resistance.
EXAMPLE 4
In this Example, the lipid vesicles from Example 1 were used in lipstick preparations. Each sample A-C was mixed using a vortex mixer in a test tube with melted lipstick base made up of the components shown below in Table 4 at a ratio of 1.0 g (vesicles) to 4.0 g (base). The samples were then placed in a water bath at 80°C. Aliquots were taken after 0, 1 , 2, 3, and 4 hours and placed on a slide, diluted with castor oil and observed under a microscope.
At each time point (0, 1, 2, 3, and 4 hours), all three Samples A-C contained dispersed lipid vesicles which had the same appearance as was observed prior to their being mixed and heated with the lipstick base. After 2 hours, a portion of the lipid vesicles in each sample had precipitated and concentrated at the bottom of the test tube, which redispersed upon vortex mixing.
These results demonstrate that lipid vesicles of the present invention made with at least one high melting point ethoxylated alcohol such as UNITHOX ™ 420, 520 or 720 remain stable when processed with other cosmetic components at high temperatures of at least 80°C for an extended period of time.
TABLE 4
Figure imgf000011_0001
EXAMPLE 5
In this Example, the lipstick preparation described in Example 4 was modified by adding various Polyethylene glycol (PEG) hydrogenated castor oil preparations (sold under the brand name CREMAPHOR™) to help disperse and maintain suspension of the lipid vesicles in the lipstick base. The PEG hydrogenated castor oil was added at both 10% total base mix (e.g., 2.5 g, as shown in Table 3) and at 5% total base mix (e.g., 1.25 g). The lipid vesicles and lipstick preparation was prepared as described in Example 3 using 1.0 g of vesicles and 9.0 g of base mix with PEG hydrogenated castor oil.
In all four Samples A-D shown in Table 5, the lipid vesicles remained stable and dispersed in the lipstick base after 2 hours at 80°C. In contrast, when adding the PEG hydrogenated castor oils at only 5% total base mix, precipitation and accumulation of vesicles was observed after 1 hour, although the precipitated vesicles were stable and fully formed. These results indicate that addition of emulsifiers such as PEG hydrogenated castor oils can help retain suspension and dispersion of the lipid vesicles of the invention in fatty cosmetic bases during and following manufacture.
TABLE 5
Figure imgf000012_0001
EQUIVALENTS
Although the invention has been described with reference to its preferred embodiments, other embodiments can achieve the same results. Those skilled in the art will recognize or be able to ascertain using no more than routine experimentation, numerous equivalents to the specific embodiments described herein. Such equivalents are considered to be within the scope of this invention and are encompassed by the following claims.

Claims

What is claimed is:
1. A lipid vesicle having one or more lipid bilayers comprising:
(a) a primary surfactant selected from the group consisting of polyoxyethylene glyceryl monostearate, polyoxyethylene glyceryl monooleate, Ci2- ιg fatty alcohols, C^-Cjg glycol monoesters, C^-Ci glyceryl mono-and diesters, and mixtures thereof;
(b) a sterol; and
(c) at least one ethoxylated alcohol having a linear C20-C50 carbon chain.
2. The lipid vesicle of claim 1 wherein the primary surfactant is selected from the group consisting of Cι6-Cι fatty alcohols, glyceryl mono- and distearate, glyceryl dilaurate, glycol stearate, and mixtures thereof.
3. The lipid vesicle of claim 1 wherein the sterol is selected from the group consisting of cholesterol, cholesterol derivatives, hydrocortisone, phytosterol, and mixtures thereof.
4. The lipid vesicle of claim 3 wherein the phytosterol is supplied from avocado oil unsaponifiables.
5. The lipid vesicle of claim 1 wherein the ethoxylated alcohol comprises 20-80% by weight ethylene oxide.
6. The lipid vesicle of claim 1 wherein the ethoxylated alcohol has a melting point of at least 80°C.
7. The lipid vesicle of claim 1 further comprising at least one secondary surfactant selected from the group consisting of polyoxyethylene acyl alcohols, C26-C18 fatty alcohols, quaternary dimethyldiacyl amines, polyoxyethylene sorbitan alcohols, polyglycerols, sorbitan fatty acid esters, fatty acids and their salts, and mixtures thereof.
8. The lipid vesicle of claim 7 wherein the secondary surfactant is selected from the group consisting of stearyl alcohol and polyoxyethylene 10-20 stearyl alcohols.
9. The lipid vesicle of claim 1 further comprising an oil.
10. The lipid vesicle of claim 9 wherein the oil is selected from the group consisting of castor oil, soybean oil, squalene oil, squalane oil, sesame oil, olive oil, canola oil, corn oil, rapeseed oil, safflower oil, sunflower oil, fish oils, avocado oil, water insoluble vitamins, and mixtures thereof.
11. The lipid vesicle of claim 1 wherein the lipid vesicle is paucilamellar.
12. A lipid vesicle having one or more lipid bilayers comprising:
(a) a primary surfactant selected from the group consisting of glyceryl mono- and distearate, glyceryl dilaurate, glycol stearate, polyoxyethylene glyceryl monostearate, polyoxyethylene glyceryl monooleate, and Cjg-Cig fatty alcohols; (b) at least one secondary selected from the group consisting of stearyl alcohol and polyoxyethylene 10-20 stearyl alcohols;
(b) a sterol selected from the group consisting of cholesterol and phytosterol; and
(c) at least one ethoxylated alcohol having a linear C20- 50 carbon chain.
13. A lipstick preparation comprising a blend of the lipid vesicle of claim 1 and a fatty lipstick base containing at least one dye.
14. A method of preparing a lipid vesicle comprising the steps of: (a) forming a lipid phase comprising a primary surfactant selected from the group consisting of polyoxyethylene glyceryl monostearate, polyoxyethylene glyceryl monooleate,
Figure imgf000015_0001
glycol monoesters,
Figure imgf000015_0002
glyceryl mono-and diesters, and mixtures thereof; a sterol; and at least one ethoxylated alcohol having a linear C20-C50 carbon chain; (b) forming and aqueous phase; and
(c) shear mixing the lipid phase and the aqueous phase to form a lipid vesicle.
15. The method of claim 14 wherein the primary surfactant is selected from the group consisting of Cjg-Ci g fatty alcohols, glycol stearate, glyceryl mono- and distearate, glyceryl dilaurate, polyoxyethylene glyceryl monostearate, and mixtures thereof.
16. The method of claim 14 wherein the sterol is selected from the group consisting of cholesterol, cholesterol derivatives, hydrocortisone, phytosterol, and mixtures thereof.
17. The method of claim 14 wherein the ethoxylated alcohol has a melting point of at least 80°C.
18. The method of claim 18 wherein the lipid phase further comprises at least one secondary surfactant selected from the group consisting of polyoxyethylene acyl alcohols, C^-Cj fatty alcohols, quaternary dimethyldiacyl amines, polyoxyethylene sorbitan alcohols, polyglycerols, sorbitan fatty acids esters, fatty acids and their salts, and mixtures thereof.
19. The method of claim 14 wherein the lipid phase further comprises an oil.
20. The method of claim 14 wherein the aqueous phase comprises at least one emulsifier.
21. A method of preparing lipstick comprising the steps of:
(a) mixing the lipid vesicle of claim 1 with a fatty lipstick base comprising at least one dye at a temperature of 80°C or higher;
(b) moulding the mixture; and (c) allowing the mixture to cool.
PCT/US1998/007451 1997-04-11 1998-04-10 Heat resistant lipid vesicles Ceased WO1998046348A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE69831144T DE69831144D1 (en) 1997-04-11 1998-04-10 HEAT-RESISTANT LIPID VESICLES
EP98915548A EP0973605B1 (en) 1997-04-11 1998-04-10 Heat resistant lipid vesicles
CA002286096A CA2286096C (en) 1997-04-11 1998-04-10 Heat resistant lipid vesicles
JP54419198A JP2001523230A (en) 1997-04-11 1998-04-10 Thermostable lipid vesicles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/838,633 US5756014A (en) 1997-04-11 1997-04-11 Heat resistant lipid vesicles
US08/838,633 1997-04-11

Publications (1)

Publication Number Publication Date
WO1998046348A1 true WO1998046348A1 (en) 1998-10-22

Family

ID=25277651

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/007451 Ceased WO1998046348A1 (en) 1997-04-11 1998-04-10 Heat resistant lipid vesicles

Country Status (6)

Country Link
US (1) US5756014A (en)
EP (1) EP0973605B1 (en)
JP (1) JP2001523230A (en)
CA (1) CA2286096C (en)
DE (1) DE69831144D1 (en)
WO (1) WO1998046348A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252830B2 (en) 2003-10-06 2007-08-07 The Gillette Company Moisturizing compositions
WO2012051406A1 (en) * 2010-10-13 2012-04-19 Sun Chemical Corporation Water dispersible solid dispersion of pigment

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039960A (en) * 1997-05-28 2000-03-21 E-L Management Corp. Water containing wax-based product
US6080211A (en) * 1999-02-19 2000-06-27 Igen, Inc. Lipid vesicle-based fuel additives and liquid energy sources containing same
JP4001310B2 (en) * 1999-09-30 2007-10-31 株式会社資生堂 Lipid complex and composition for external use containing the same
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
DE10116497B4 (en) * 2001-04-03 2004-08-12 Faber-Castell Ag Liquid for lip care or lip coloring
WO2006014035A1 (en) * 2004-08-06 2006-02-09 Biospectrum, Inc. Multiple layered liposome and preparation method thereof
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
US8449979B2 (en) * 2005-01-28 2013-05-28 Japan Science And Technology Agency Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
US10251839B2 (en) * 2008-01-22 2019-04-09 Igi Laboratories, Inc. Lipid vesicles derived from olive oil fatty acids
GB0920879D0 (en) * 2009-11-27 2010-01-13 Revolymer Ltd Cosmetic composition
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) * 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
GR1008481B (en) * 2013-12-05 2015-05-12 Συμβουλοι Αναπτυξης Πωλησεων Επε, Method for the confinement of plant oils (olive oil) with use of specific edible liposomes without phospholipids- application of said method in food, charcuterie, dairy products and fish preparations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405615A (en) * 1991-09-17 1995-04-11 Micro Vesicular Systems, Inc. Sucrose distearate lipid vesicles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603659B2 (en) * 1987-03-13 1990-11-22 Micro Vesicular Systems, Inc. Lipid vesicles formed of surfactants and steroids
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
AU715468B2 (en) * 1995-06-22 2000-02-03 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405615A (en) * 1991-09-17 1995-04-11 Micro Vesicular Systems, Inc. Sucrose distearate lipid vesicles

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252830B2 (en) 2003-10-06 2007-08-07 The Gillette Company Moisturizing compositions
WO2012051406A1 (en) * 2010-10-13 2012-04-19 Sun Chemical Corporation Water dispersible solid dispersion of pigment

Also Published As

Publication number Publication date
EP0973605A1 (en) 2000-01-26
DE69831144D1 (en) 2005-09-15
EP0973605B1 (en) 2005-08-10
CA2286096C (en) 2006-03-14
EP0973605A4 (en) 2000-04-19
JP2001523230A (en) 2001-11-20
US5756014A (en) 1998-05-26
CA2286096A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
US5756014A (en) Heat resistant lipid vesicles
JP3411570B2 (en) Blended lipid vesicles
EP0727982B1 (en) Propylene glycol stearate vesicles
EP0534286B1 (en) External skin care preparation
KR101337811B1 (en) Process for producing o/w microemulsion preparation for external application
US6479041B2 (en) Method for producing aqueous emulsions or suspensions
JPH10500675A (en) Pharmaceutical compositions derived from microemulsion-based gels, methods for their preparation and novel microemulsion-based gels
US5994414A (en) Water-thin emulsion formed by high pressure homogenization process
KR20010013086A (en) Water containing wax-based product
CA2175471C (en) Sucrose distearate lipid vesicles
EP1280497A2 (en) Rinse-off cosmetic conditioning compositions
EP1069882A1 (en) Di-behenyl fumarate and its use in dermatological products
JPS6157838B2 (en)
CN102655840A (en) Personal care emulsions comprising waxy materials and organopolysiloxanes
JP2002526399A (en) Glucoside pouch lamellar vesicle
US6844009B1 (en) Media in the form of complex dispersions, method for preparing same and uses
JPS63221835A (en) Method for producing stable oil-in-water emulsion
JPH09510432A (en) Lipid vesicles containing unsaponifiable avocado oil
JPH08268829A (en) Emulsion type composition
JP2026001832A (en) Fragrant three-phase emulsion composition
CN119770382A (en) Emulsifying wax for solid cosmetic compositions
CN120884538A (en) A one-step method for preparing water-in-oil-in-water multi-component liquid crystal emulsions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2286096

Country of ref document: CA

Ref country code: CA

Ref document number: 2286096

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 544191

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998915548

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998915548

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1998915548

Country of ref document: EP